FIELD: pharmacology.
SUBSTANCE: as compound, possessing antispasmodic activity claimed is dihydrochloride 9-dialkylaminoethyl-2-(4-chlorophenyl)imidazol[1,2-a]benzimidazole of general formula I where Ia NR2= dimethylamino- Ib NR2 = diethylamino-. Therapeutic index of dihydrochloride 9-dialkylaminoethyl-2-(4-chlorophenyl)imidazol[1,2-a]benzimidazole was in 10 times higher than of sodium valproate.
EFFECT: antispasmodic activity of compounds exceeding activity of sodium valproate has been identified.
2 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTICONVULSANT | 2014 |
|
RU2572711C1 |
METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE | 2013 |
|
RU2518740C1 |
KAPPA-OPIOID AGONIST | 2009 |
|
RU2413512C1 |
11-(4-TERT-BUTYLBENZYL)-2,3,4,5-TETRAHYDRO[1,3]DYAZEPINO[1,2-A]BENZIMIDAZOLE HYDROBROMIDE WITH ANXIOLYTIC AND ANTICONVULSANT ACTIVITY | 2017 |
|
RU2662242C1 |
ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
METHOD OF DETECTING ANTICONVULSANT ACTION OF SODIUM CITICOLINE AND VALPROATE WHEN APPLYING THEM TOGETHER ON MODEL OF ACUTE GENERALIZED CONVULSIONS CAUSED BY PENTYLENETETRAZOLE IN WISTAR MALE RATS | 2015 |
|
RU2600477C1 |
MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM | 2013 |
|
RU2518741C1 |
AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
2-ARYL-4-DIALKYLAMINOETHYL-3-PHENYLPYRROLO[1,2-a]-BENZIMIDAZOLE SULPHATES, HAVING ANTIOXIDANT AND ANTIRADICAL PROPERTIES | 2010 |
|
RU2443704C1 |
Authors
Dates
2015-11-20—Published
2014-09-19—Filed